Literature DB >> 26590996

Impact of microparticles derived from erythrocytes on fibrinolysis.

Grigory Levin1, Ekaterina Sukhareva2, Athina Lavrentieva3.   

Abstract

It has long been known that negatively charged membranes of erythrocyte-derived microparticles display procoagulant activity. However, relatively little is known about the possible fibrinolytic activity of such microparticles. This issue becomes particularly important during red blood cell storage, which significantly increases the number of microparticles. Whole blood was collected from 30 healthy donors. Microparticles were isolated on days 7, 14, 21, and 28 of erythrocyte storage. The effect of microparticles on the fibrinolytic activity of the donor plasma was determined by coagulation and optical (chromogenic substrate) methods. We demonstrated that erythrocyte microparticles had a prominent fibrinolytic activity which cleaves not only fibrin but also chromogenic substrates. Microparticles present fibrinolytic activity mainly due to the presence of plasminogen on them. Microparticles derived from erythrocytes significantly enhance cleavage of the chromogenic substrate by the streptokinase-plasminogen complex, but to a lesser extent accelerate euglobulin clot lysis time. Erythrocyte-derived microparticles display prominent fibrinolytic activity, which significantly decreases during storage of red blood cells.

Entities:  

Keywords:  Blood safety; Hemostasis; Plasma; Red cell components; Transfusion medicine (in general)

Mesh:

Year:  2016        PMID: 26590996     DOI: 10.1007/s11239-015-1299-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  29 in total

Review 1.  Platelet-derived microvesicles: multitalented participants in intercellular communication.

Authors:  Maria Aatonen; Mikaela Grönholm; Pia R-M Siljander
Journal:  Semin Thromb Hemost       Date:  2012-02-07       Impact factor: 4.180

Review 2.  Microparticles in stored red blood cells: submicron clotting bombs?

Authors:  Olivier Rubin; David Crettaz; Jean-Daniel Tissot; Niels Lion
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

Review 3.  Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome.

Authors:  T Lhermusier; H Chap; B Payrastre
Journal:  J Thromb Haemost       Date:  2011-10       Impact factor: 5.824

4.  The release of microparticles by apoptotic cells and their effects on macrophages.

Authors:  J H W Distler; L C Huber; A J Hueber; C F Reich; S Gay; O Distler; D S Pisetsky
Journal:  Apoptosis       Date:  2005-08       Impact factor: 4.677

5.  The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.

Authors:  Grigoris T Gerotziafas; Patrick Van Dreden; Mourad Chaari; Vassiliki Galea; Amir Khaterchi; Francois Lionnet; Katice Stankovic-Stojanovic; Olivier Blanc-Brude; Barry Woodhams; Micheline Maier-Redelsperger; Robert Girot; Mohamed Hatmi; Ismail Elalamy
Journal:  Thromb Haemost       Date:  2012-04-26       Impact factor: 5.249

Review 6.  Platelets and platelet-derived microparticles in vascular inflammatory disease.

Authors:  Elena Vasina; Johan W M Heemskerk; Christian Weber; Rory R Koenen
Journal:  Inflamm Allergy Drug Targets       Date:  2010-12

7.  Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation.

Authors:  Ritha M Belizaire; Priya S Prakash; Jillian R Richter; Bryce R Robinson; Michael J Edwards; Charles C Caldwell; Alex B Lentsch; Timothy A Pritts
Journal:  J Am Coll Surg       Date:  2012-02-17       Impact factor: 6.113

8.  Plasminogen activation by streptokinase via a unique mechanism.

Authors:  K C Young; G Y Shi; D H Wu; L C Chang; B I Chang; C P Ou; H L Wu
Journal:  J Biol Chem       Date:  1998-01-30       Impact factor: 5.157

Review 9.  Cellular microparticles: new players in the field of vascular disease?

Authors:  M Diamant; M E Tushuizen; A Sturk; R Nieuwland
Journal:  Eur J Clin Invest       Date:  2004-06       Impact factor: 4.686

10.  The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

View more
  6 in total

1.  Preclinical Evaluation of Safety and Biodistribution of Red Cell Microparticles: A Novel Hemostatic Agent.

Authors:  Ashish K Rehni; Vibha Shukla; Hever Navarro Quero; Carlos Bidot; Conner R Haase; Ensign Anise A Crane; Shivam G Patel; Sebastian Koch; Yeon S Ahn; Wenche Jy; Kunjan R Dave
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-04-29       Impact factor: 2.457

Review 2.  Red blood cells: the forgotten player in hemostasis and thrombosis.

Authors:  J W Weisel; R I Litvinov
Journal:  J Thromb Haemost       Date:  2019-01-07       Impact factor: 5.824

3.  Red Blood Cell Microparticles Limit Hematoma Growth in Intracerebral Hemorrhage.

Authors:  Ashish K Rehni; Sunjoo Cho; Hever Navarro Quero; Vibha Shukla; Zhexuan Zhang; Chuanhui Dong; Weizhao Zhao; Miguel A Perez-Pinzon; Sebastian Koch; Wenche Jy; Kunjan R Dave
Journal:  Stroke       Date:  2022-09-07       Impact factor: 10.170

Review 4.  Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants.

Authors:  Murray M Bern
Journal:  Clin Transl Med       Date:  2017-09-21

Review 5.  Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy.

Authors:  Kiruphagaran Thangaraju; Sabari Nath Neerukonda; Upendra Katneni; Paul W Buehler
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

6.  Interaction of von Willebrand factor with blood cells in flow models: a systematic review.

Authors:  Ryanne A Arisz; Judith J de Vries; Saskia E M Schols; Jeroen C J Eikenboom; Moniek P M de Maat
Journal:  Blood Adv       Date:  2022-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.